My Quote Request
No products added yet
6505-01-304-1014
20 Products
NDC58177-0005-04
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC58177-0005-04
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
ETHEX CORP SUB OF K-V PHARMACEUTICAL CO
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013038964
NSN
6505-01-303-8964
HEXABRIX
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013038964
NSN
6505-01-303-8964
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MALLINCKRODT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00019-5505-10
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013038964
NSN
6505-01-303-8964
NDC00019-5505-10
IOXAGLATE MEGLUMINE AND IOXAGLATE SODIUM,USP
NSN, MFG P/N
6505013038964
NSN
6505-01-303-8964
MFG
MALLINCKRODT INC ANESTHESIA PRODUCTS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 39.300 PERCENTAGE, W/V IOTHALAMATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOTHALAMATE SODIUM ACTIVE INGREDIENT
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,MALLINCKRODT
PRIMARY CONTAINER CONTENT QUANTITY: 15.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 12
Related Searches:
NDC00206-3882-28
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505013040788
NSN
6505-01-304-0788
NDC00206-3882-28
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505013040788
NSN
6505-01-304-0788
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 GRAMS PIPERACILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM STERILE USP POWDER FORM 3GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW; ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION; 6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: CTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
NDC63323-0381-20
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505013040788
NSN
6505-01-304-0788
NDC63323-0381-20
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505013040788
NSN
6505-01-304-0788
MFG
AMERICAN PHARMACEUTICAL PARTNERS
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 GRAMS PIPERACILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM STERILE USP POWDER FORM 3GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW; ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION; 6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: CTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
PIPRACIL
PIPERACILLIN SODIUM,USP
NSN, MFG P/N
6505013040788
NSN
6505-01-304-0788
MFG
AMERICAN CYANAMID CO LEDERLE LABORATORIES DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 3.000 GRAMS PIPERACILLIN EQUIVALENT
III PART NAME ASSIGNED BY CONTROLLING AGENCY: PIPERACILLIN SODIUM STERILE USP POWDER FORM 3GM VIAL 10S
PHYSICAL FORM: POWDER
PRIMARY CONTAINER CONTENT QUANTITY: 3.000 GRAMS OF ACTIVE INGREDIENT
PRIMARY CONTAINER TYPE: VIAL, SINGLE DOSE
SPECIAL FEATURES: 18 ML CAPACITY GLASS VIAL,WITH INTERLOCKING DOUBLE LEAD SCREW; ENCLOSED IN UPPER AND LOWER PLASTIC SHROUD; FOR USE WITH DEXTROSE INJECTION; 6505-01-260-1237,6505-01-260-1238,AND 6505-01-260-1239 AND SODIUM CHLORIDE INJE
TOTAL PRIMARY CONTAINER QUANTITY: 10
~1: CTION,6505-01-260-1241,6505-01-260-1242,AND 6505-01-260-6715
Related Searches:
4A8931
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
4A8931
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
MFG
ABBOTT LABORATORIES PHARMACEUTICAL PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 GRAMS CITRIC ACID (ANHYDROUS) PER 100 ML; 2.630 GRAMS SODIUM CITRATE (DIHYDRATE) PER 100 ML; 0.220 GRAMS MONOBASIC SODIUM PHOSPHATE PER 100 ML; 2.550 GRAMS DEXTROSE (MONOHYDRATE) PER 100 ML
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOL USP 500ML BT 6S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
A89F024
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
A89F024
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
MFG
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMT-D
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 GRAMS CITRIC ACID (ANHYDROUS) PER 100 ML; 2.630 GRAMS SODIUM CITRATE (DIHYDRATE) PER 100 ML; 0.220 GRAMS MONOBASIC SODIUM PHOSPHATE PER 100 ML; 2.550 GRAMS DEXTROSE (MONOHYDRATE) PER 100 ML
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOL USP 500ML BT 6S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00074-1967-04
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
NDC00074-1967-04
ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOLUTION,USP
NSN, MFG P/N
6505013041007
NSN
6505-01-304-1007
MFG
ABBOTT LABORATORIES INC ROSS PRODUCTS DIV
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 0.300 GRAMS CITRIC ACID (ANHYDROUS) PER 100 ML; 2.630 GRAMS SODIUM CITRATE (DIHYDRATE) PER 100 ML; 0.220 GRAMS MONOBASIC SODIUM PHOSPHATE PER 100 ML; 2.550 GRAMS DEXTROSE (MONOHYDRATE) PER 100 ML
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE SOL USP 500ML BT 6S
III SUPPLEMENTARY FEATURES: MEDSEP ITEM FOR DOD,ABBOTT LABS
PRIMARY CONTAINER CONTENT QUANTITY: 500.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE
TOTAL PRIMARY CONTAINER QUANTITY: 6
Related Searches:
NDC00065-0647-05
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
NDC00065-0647-05
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
MFG
VETERANS HEALTH
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.000 MILLIGRAMS TOBRAMYCIN PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
TOBRADEX
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
TOBRADEX
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.000 MILLIGRAMS TOBRAMYCIN PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
TOBRADEX EYE DROPS
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
TOBRADEX EYE DROPS
TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION
NSN, MFG P/N
6505013041008
NSN
6505-01-304-1008
MFG
ALCON LABORATORIES INC .
Description
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 1.000 MILLIGRAMS DEXAMETHASONE PER MILLILITER AND 3.000 MILLIGRAMS TOBRAMYCIN PER MILLILITER
FEATURES PROVIDED: STERILE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION 5ML BT
PRIMARY CONTAINER CONTENT QUANTITY: 5.000 MILLILITERS
PRIMARY CONTAINER TYPE: BOTTLE WITH OPHTHALMIC TIP
Related Searches:
NDC00182-0703-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00182-0703-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
GOLDLINE LABORATORIES GOVERNMENT SALES DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00182-0703-89
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00182-0703-89
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
IVAX
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00185-1235-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00185-1235-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
EON LABS INC.
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00603-4783-21
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00603-4783-21
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
GENERICS BIDCO I LLC DBA QUALITEST PHARMACEUTICALS
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00677-0486-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00677-0486-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
BAXTER HEALTHCARE CORP BAXTER AIRLIFE/PHARMASEAL DIV
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00781-2786-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00781-2786-01
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
GENEVA PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC00904-0644-60
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC00904-0644-60
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
MAJOR PHARMACEUTICALS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
Related Searches:
NDC49483-0222-10
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
NDC49483-0222-10
NITROGLYCERIN EXTENDED-RELEASE CAPSULES
NSN, MFG P/N
6505013041014
NSN
6505-01-304-1014
MFG
TIME-CAP LABS INC
Description
(NON-CORE DATA) EXTERIOR CONTAINER CUBIC MEASURE: 0.9888 CUBIC FEET
(NON-CORE DATA) EXTERIOR CONTAINER QUANTITY: 72
(NON-CORE DATA) EXTERIOR CONTAINER WEIGHT: 14.00 POUNDS
(NON-CORE DATA) UNIT OF ISSUE CUBE: 0.0137 CUBIC FEET
(NON-CORE DATA) UNIT OF ISSUE WEIGHT: 0.1944 POUNDS
ACTIVE MEDICAMENT MEDICINAL STRENGTH: 6.500 MILLIGRAMS NITROGLYCERIN ACTIVE INGREDIENT
CAPSULE CONTENT FORM: POWDER
CAPSULE PRIMARY CONTAINER CONTENT QUANTITY: 100.000
CAPSULE TYPE: HARD
FEATURES PROVIDED: CHILD RESISTANT CLOSURE
III PART NAME ASSIGNED BY CONTROLLING AGENCY: NITROGLYCERIN EXTENDED-RELEASE CAPSULES 6.5MG 100S BT
LONG ACTION METHOD: EXTENDED RELEASE
PRIMARY CONTAINER TYPE: BOTTLE
